First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · Real-Time Price · USD
27.59
+0.21 (0.78%)
Nov 21, 2024, 11:23 AM EST - Market open
FTXH Holdings List
As of Nov 18, 2024
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | BMY | Bristol-Myers Squibb Company | 8.92% |
| 2 | JNJ | Johnson & Johnson | 7.32% |
| 3 | PFE | Pfizer Inc. | 6.72% |
| 4 | ABBV | AbbVie Inc. | 6.64% |
| 5 | MRK | Merck & Co., Inc. | 6.39% |
| 6 | GILD | Gilead Sciences, Inc. | 4.39% |
| 7 | VTRS | Viatris Inc. | 4.22% |
| 8 | CAH | Cardinal Health, Inc. | 4.17% |
| 9 | ZTS | Zoetis Inc. | 3.77% |
| 10 | UTHR | United Therapeutics Corporation | 3.74% |
| 11 | JAZZ | Jazz Pharmaceuticals plc | 3.37% |
| 12 | AMGN | Amgen Inc. | 3.27% |
| 13 | BIIB | Biogen Inc. | 3.02% |
| 14 | LLY | Eli Lilly and Company | 2.97% |
| 15 | REGN | Regeneron Pharmaceuticals, Inc. | 2.52% |
| 16 | OGN | Organon & Co. | 2.48% |
| 17 | CRL | Charles River Laboratories International, Inc. | 2.43% |
| 18 | ELAN | Elanco Animal Health Incorporated | 1.81% |
| 19 | MEDP | Medpace Holdings, Inc. | 1.71% |
| 20 | NBIX | Neurocrine Biosciences, Inc. | 1.37% |
| 21 | EXEL | Exelixis, Inc. | 1.14% |
| 22 | ALKS | Alkermes plc | 1.07% |
| 23 | PRGO | Perrigo Company plc | 1.00% |
| 24 | PBH | Prestige Consumer Healthcare Inc. | 0.99% |
| 25 | HALO | Halozyme Therapeutics, Inc. | 0.97% |
| 26 | CORT | Corcept Therapeutics Incorporated | 0.81% |
| 27 | PTGX | Protagonist Therapeutics, Inc. | 0.72% |
| 28 | ACLX | Arcellx, Inc. | 0.70% |
| 29 | TGTX | TG Therapeutics, Inc. | 0.69% |
| 30 | INCY | Incyte Corporation | 0.64% |
| 31 | ADMA | ADMA Biologics, Inc. | 0.61% |
| 32 | ITCI | Intra-Cellular Therapies, Inc. | 0.61% |
| 33 | ALNY | Alnylam Pharmaceuticals, Inc. | 0.60% |
| 34 | ACAD | ACADIA Pharmaceuticals Inc. | 0.56% |
| 35 | VCEL | Vericel Corporation | 0.56% |
| 36 | AMRX | Amneal Pharmaceuticals, Inc. | 0.52% |
| 37 | TWST | Twist Bioscience Corporation | 0.52% |
| 38 | BPMC | Blueprint Medicines Corporation | 0.51% |
| 39 | RNA | Avidity Biosciences, Inc. | 0.51% |
| 40 | VRTX | Vertex Pharmaceuticals Incorporated | 0.51% |
| 41 | ROIV | Roivant Sciences Ltd. | 0.50% |
| 42 | KRYS | Krystal Biotech, Inc. | 0.49% |
| 43 | KYMR | Kymera Therapeutics, Inc. | 0.48% |
| 44 | INSM | Insmed Incorporated | 0.47% |
| 45 | EXAS | Exact Sciences Corporation | 0.44% |
| 46 | SRPT | Sarepta Therapeutics, Inc. | 0.42% |
| 47 | VKTX | Viking Therapeutics, Inc. | 0.42% |
| 48 | BMRN | BioMarin Pharmaceutical Inc. | 0.42% |
| 49 | IONS | Ionis Pharmaceuticals, Inc. | 0.39% |
| 50 | MYGN | Myriad Genetics, Inc. | 0.29% |
As of Nov 18, 2024